Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is proud to announce winners of its 17th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition and 2017 Best Poster Contests for student pharmacists, residents or fellows, and graduate students.
Press Release: Four thousand managed care pharmacy professionals and stakeholders from across the country have traveled to Denver, Colorado, this week for the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting.
Press Release: Managed care pharmacy professionals have the expertise necessary to help lawmakers develop policies for an effective pharmaceutical benefit under any new health care reform bill that may emerge in the weeks and months ahead.
Press Release: Association TRENDS magazine today recognized Academy of Managed Care Pharmacy (AMCP) Foundation Executive Director Paula J. Eichenbrenner, CAE, as a “Young & Aspiring” Association Executive.
Press Release: February’s themed issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) examines challenges that managed care pharmacists face in administering oncology therapies, including considerations around patient-reported outcomes and the role of caregivers.
Press Release: The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.
Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the Food and Drug Administration (FDA) for its release today of draft guidance clarifying how biopharmaceutical companies and population health decision makers can proactively share clinical and economic information on both FDA approved products as well as emerging therapies awaiting FDA approval.
Press Release: The Academy of Managed Care Pharmacy (AMCP) has released a set of consensus recommendations to allow biopharmaceutical companies to proactively share clinical and economic information with population health decision makers on emerging therapies in advance of Food and Drug Administration (FDA) approval.
Press Releases: Total costs of treating heart-failure (HF) patients escalate nearly three-fold in the final six months of life, driven overwhelmingly by hospitalizations.
Press Releases: Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, issued the following statement on President Obama’s signing today of the 21st Century Cures Act.
Press Releases: The Addiction Treatment Advisory Group (ATAG), created last year by the Academy of Managed Care Pharmacy (AMCP), has released detailed findings on how managed care organizations can better address the opioid addiction crisis, including through improved access to naloxone and Medication Assisted Therapies (MAT).
Press Releases: Learn more about AMCP Foundation Issues Two Major Reports: Symposium Report on Balancing Access and Use of Opioid Therapies; and Assessment of Future Health Care Trends
Press Releases: Academy of Managed Care Pharmacy CEO Susan A. Cantrell, RPh, CAE, issued the following statement on the House passage of the 21st Century Cures Act.
Press Releases: The Academy of Managed Care Pharmacy (AMCP) is pleased to announce the recent appointment of Chris Lyons in the new role of AMCP Chief Operating Officer.
Press Releases: The accelerating pace of oncology innovation and the complexity of cancer treatments were key themes underlying the discussion of value and outcomes in oncology at a national health care forum hosted this week by the Academy of Managed Care Pharmacy (AMCP).
Press Release: Pharmacy professional organizations and stakeholders today released a standardized framework for documenting medication therapy management (MTM) services using SNOMED CT (Systematized Nomenclature of Medicine.
Press Release: A Briefing for Congressional Staff who focus on healthcare, and anyone interested in pharmaceutical pricing, Sponsored by the Academy of Managed Care Pharmacy
Press Release: The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) this month reached a significant new phase of operation, posting research protocols that will lay the groundwork for comparative effectiveness and safety studies of biosimilars currently available or projected to enter the market next year.